Task: Answer the multiple choice question.
Question: Which compound exhibits a -9.122% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: O=C(CN1C(=O)C(=O)N(C2CCCC2)C1=O)Nc1ccc(OC(F)F)cc1
b: Cc1sc2nc3ccc(N4CCCCC4)nn3c(=O)c2c1C
c: CC(C)OCC1CC(CC(=O)NC(=S)Nc2cccc([N+](=O)[O-])c2)C(=O)O1
Answer: b. Cc1sc2nc3ccc(N4CCCCC4)nn3c(=O)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2nc3ccc(N4CCCCC4)nn3c(=O)c2c1C
Cc1sc2nc3ccc(N4CCCCC4)nn3c(=O)c2c1C
4,5-dimethyl-12-piperidin-1-yl-6-thia-1,8,13-triazatricyclo[7.4.0.03,7]trideca-3(7),4,8,10,12-pentaen-2-one